Plant-based protein company Beyond Meat (NASDAQ:BYND) announced in Q4 CY2024, with sales up 4% year on year to $76.66 million ...
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) in Q4 CY2024, with sales up 35% year on year to $282.6 million ...
Biotech giant Renegeron Pharmaceuticals (NASDAQ: REGN) reported its fourth-quarter and full-year 2024 earnings on Feb. 4. The company's results were strong, coming in ahead of analyst estimates.
Biotech company Sarepta Therapeutics (NASDAQ:SRPT) announced in Q4 CY2024, with sales up 65.9% year on year to $658.4 million ...
Plant-based food and beverage company SunOpta (NASDAQ:STKL) in Q4 CY2024, with sales up 6.8% year on year to $193.9 million.
Palantir Technology's (NASDAQ: PLTR) stock has been nearly unstoppable ... That shows that both the underlying company and the market opportunity are strong. Although Palantir attained a $236 ...
Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...
Leading edge card issuer Marqeta (NASDAQ: MQ) in Q4 CY2024, with sales up 14.3% year on year to $135.8 million. Guidance for ...
SHELTON, CT / ACCESS Newswire / February 18, 2025 / The Eastern Company (NASDAQ:EML), an industrial manufacturer of unique engineered solutions serving commercial transportation, logistics ...